CalbaTech, Inc.'s LifeStem Subsidiary Announces Joint Venture Agreement with Major California Medical Institute
LAGUNA HILLS, Calif., Feb. 20 /PRNewswire-FirstCall/ -- CalbaTech, Inc. , the emerging life sciences company (http://www.CalbaTech.com) concentrating on the collection and banking of adult stem cells for possible future therapeutic uses, today announced that LifeStem(TM) Inc., its wholly owned subsidiary, has signed a joint venture agreement with Keller Medical Institute (KMI), Monterey, California, for Keller medical professionals to be trained in the procedures of the Stem Cell Microbank(TM) Service.
The training and protocols will allow Keller clinics, including its joint venture weight clinics and dental sites, to market and sell the Stem Cell Microbank(TM) Service. "This is a very important step forward for LifeStem(TM) because of the excellent reputation of Keller Medical. We also anticipate announcing further collection services in the near future," said James DeOlden, CEO.
KMI, which is a very well respected medical group, will also teach the service to visiting doctors, surgeons and dentists on an ongoing basis. These doctors come to Keller to learn about the newest advancements and the LifeStem(TM) service will be taught to each. KMI is also dedicated to bringing the service to Fortune 1000 companies that self insure and are interested in keeping down their costs by using health and wellness programs, for which the LifeStem(TM) service could play a unique role. KMI is also in the process of expanding to eight new locations throughout the U.S., all of which will offer this adult stem cell collection service.
The procedure developed by LifeStem(TM) involves the collection of both blood and adipose tissue to harvest healthy adult stem cells for potential future medical use. The unique process allows for the collection of adult stem cells in micro quantities to be cryopreserved for future transplantation into the same client with possible therapies ranging from heart disease to diabetes and other medical issues that are currently difficult to treat.
Keller Medical Institute is known for setting the standard for personalized medicine and widely acclaimed for utilizing the latest discoveries in procedural technologies, DNA analysis, pharmacology and cellular chemistry to help clients look and feel their best. "We are delighted with our association with LifeStem(TM) and this opportunity to bring cutting edge medical advancements to our patients," said Robert Keller, M.D., founder.
About CalbaTech
CalbaTech, Inc. is the emerging life sciences company (http://www.CalbaTech.com), concentrating on providing products and platforms to the research market for biotech and pharmaceutical companies and to academic institutions, as well as providing services in the collection, processing and storage of adult stem cells.
Note: Certain statements in this news release may contain "forward-looking" information within the meaning of rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Act of 1934 and are subject to the safe harbor created by those rules. We use words such as "anticipate," "believe," "expect," "future," "intend," "plan," and similar expressions to identify forward-looking statements. These statements including those related to being in a large and growing market, exhibiting rapid growth characteristics, and having a growth strategy, are forward looking statements. These forward looking statements are only predictions and are subject to certain risks, uncertainties and assumptions. Some of the risks, uncertainties and assumptions that could cause actual results to differ materially from estimates or assumptions in this press release include the risk that we will not be able to grow our revenues and market share, the risk that our prices do not remain competitive and the risk that we will not achieve profitability. Additional risks are identified and described in the Company's public filings with the Securities and Exchange Commission, including our most recent Report on Form 10-KSB, and Reports on Form 10-QSB and Form 8-K. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company's past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims, any obligation to update any forward-looking statements to reflect occurrences, developments, events, or circumstances after the date of such statement.
pknopick@eandecommunications.com
CONTACT: Paul Knopick of E&E Communications, +1-949-707-5365,
pknopick@eandecommunications.com, for CalbaTech, Inc.
Web site: http://www.CalbaTech.com/